{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:21:43Z","timestamp":1740108103186,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00106-022-01188-4","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T17:03:04Z","timestamp":1654880584000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strahlentherapie von malignen Speicheldr\u00fcsentumoren","Radiation therapy of malignant salivary gland tumors"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-484X","authenticated-orcid":false,"given":"Katharina","family":"Weusthof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"issue":"2","key":"1188_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","volume":"74","author":"M Guzzo","year":"2010","unstructured":"Guzzo\u00a0M et\u00a0al (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74(2):134\u2013148","journal-title":"Crit Rev Oncol Hematol"},{"key":"1188_CR2","volume-title":"World health organization classification of tumours of head and neck","author":"A El-Naggar","year":"2017","unstructured":"El-Naggar\u00a0A et al (2017) World health organization classification of tumours of head and neck. IARC, Lyon"},{"issue":"3","key":"1188_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9","volume":"69","author":"JG Armstrong","year":"1992","unstructured":"Armstrong\u00a0JG et\u00a0al (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69(3):615\u2013619","journal-title":"Cancer"},{"issue":"4","key":"1188_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/0002-9610(75)90483-3","volume":"130","author":"RH Spiro","year":"1975","unstructured":"Spiro\u00a0RH, Huvos\u00a0AG, Strong\u00a0EW (1975) Cancer of the parotid gland: A clinicopathologic study of 288 primary cases. Am J Surg 130(4):452\u2013459","journal-title":"Am J Surg"},{"key":"1188_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580141","author":"L Di Villeneuve","year":"2020","unstructured":"Di Villeneuve\u00a0L et al (2020) Salivary gland carcinoma: novel targets to overcome treatment resistance in advanced disease. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.580141","journal-title":"Front Oncol"},{"issue":"2","key":"1188_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/1097-0142(19860115)57:2<312::AID-CNCR2820570220>3.0.CO;2-A","volume":"57","author":"AG Nascimento","year":"1986","unstructured":"Nascimento\u00a0AG et\u00a0al (1986) Adenoid cystic carcinoma of salivary glands. A study of 61\u00a0cases with clinicopathologic correlation. Cancer 57(2):312\u2013319","journal-title":"Cancer"},{"key":"1188_CR7","unstructured":"N.C.C.N., NCCN Clinical Practice Guidelines in Oncology\u2014Head and Neck Cancers. 2021(3.2021 )."},{"issue":"17","key":"1188_CR8","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger\u00a0JL et\u00a0al (2021) Management of salivary gland malignancy: ASCO guideline. J\u00a0Clin Oncol 39(17):1909\u20131941","journal-title":"J Clin Oncol"},{"issue":"S2","key":"1188_CR9","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1017\/S0022215116000566","volume":"130","author":"S Sood","year":"2016","unstructured":"Sood\u00a0S, McGurk\u00a0M, Vaz\u00a0F (2016) Management of salivary gland tumours: United Kingdom national multidisciplinary guidelines. J\u00a0Laryngol Otol 130(S2):S142\u2013S149","journal-title":"J Laryngol Otol"},{"issue":"1","key":"1188_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13014-016-0657-z","volume":"11","author":"AD Jensen","year":"2016","unstructured":"Jensen\u00a0AD et al (2016) Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation? Radiat Oncol 11(1):90","journal-title":"Radiat Oncol"},{"issue":"1","key":"1188_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijrobp.2015.05.013","volume":"93","author":"AD Jensen","year":"2015","unstructured":"Jensen\u00a0AD et al (2015) COSMIC: a regimen of intensity modulated radiation therapy plus dose-escalated, raster-scanned carbon Ion boost for malignant salivary gland tumors: results of the prospective phase 2 trial. Int J Radiat Oncol Biol Phys 93(1):37\u201346","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1188_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00405-011-1663-2","volume":"269","author":"M Stenner","year":"2012","unstructured":"Stenner\u00a0M et al (2012) Occurrence of lymph node metastasis in early-stage parotid gland cancer. Eur Arch Otorhinolaryngol 269(2):643\u2013648","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"1188_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/coa.12672","volume":"42","author":"MF Meyer","year":"2017","unstructured":"Meyer\u00a0MF et\u00a0al (2017) Prediction of outcome by lymph node ratio in patients with parotid gland cancer. Clin Otolaryngol 42(1):98\u2013103","journal-title":"Clin Otolaryngol"},{"issue":"3","key":"1188_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archotol.1990.01870030054008","volume":"116","author":"JG Armstrong","year":"1990","unstructured":"Armstrong\u00a0JG et al (1990) Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg 116(3):290\u2013293","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"10","key":"1188_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/0360-3016(86)90314-7","volume":"12","author":"PJ Fitzpatrick","year":"1986","unstructured":"Fitzpatrick\u00a0PJ, Theriault\u00a0C (1986) Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 12(10):1743\u20131747","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1188_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/j.1930-2398.1988.tb00006.x","volume":"10","author":"LJ Eapen","year":"1988","unstructured":"Eapen\u00a0LJ et\u00a0al (1988) Impact of local radiation in the management of salivary gland carcinomas. Head Neck Surg 10(4):239\u2013245","journal-title":"Head Neck Surg"},{"issue":"3","key":"1188_CR17","first-page":"183","volume":"166","author":"C Glanzmann","year":"1990","unstructured":"Glanzmann\u00a0C (1990) Long-term results of postoperative and primary radiotherapy of carcinoma of the salivary glands: importance of dosage and target volume. Strahlenther Onkol 166(3):183\u2013189","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"1188_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/lary.27444","volume":"129","author":"S Cheraghlou","year":"2019","unstructured":"Cheraghlou\u00a0S et al (2019) Adjuvant chemotherapy is associated with improved survival for late-stage salivary squamous cell carcinoma. Laryngoscope 129(4):883\u2013889","journal-title":"Laryngoscope"},{"issue":"3","key":"1188_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/hed.20327","volume":"28","author":"J Gilbert","year":"2006","unstructured":"Gilbert\u00a0J et\u00a0al (2006) Phase II trial of taxol in salivary gland malignancies (E1394): a\u00a0trial of the Eastern Cooperative Oncology Group. Head Neck 28(3):197\u2013204","journal-title":"Head Neck"},{"issue":"3","key":"1188_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.radonc.2009.10.012","volume":"93","author":"F Duprez","year":"2009","unstructured":"Duprez\u00a0F et al (2009) Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol 93(3):563\u2013569","journal-title":"Radiother Oncol"},{"issue":"1107","key":"1188_CR21","doi-asserted-by":"publisher","first-page":"20190516","DOI":"10.1259\/bjr.20190516","volume":"93","author":"K Seidensaal","year":"2020","unstructured":"Seidensaal\u00a0K et al (2020) Re-irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies. Br J Radiol 93(1107):20190516","journal-title":"Br J Radiol"},{"issue":"12","key":"1188_CR22","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO;2-Y","volume":"60","author":"AI Dreyfuss","year":"1987","unstructured":"Dreyfuss\u00a0AI et\u00a0al (1987) Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 60(12):2869\u20132872","journal-title":"Cancer"},{"issue":"11","key":"1188_CR23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jamaoto.2016.2168","volume":"142","author":"A Amini","year":"2016","unstructured":"Amini\u00a0A et\u00a0al (2016) Association of adjuvant chemoradiotherapy vs radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the national cancer data base. JAMA Otolaryngol Head Neck Surg 142(11):1100\u20131110","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1188_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-07024-9","author":"V Freitag","year":"2021","unstructured":"Freitag\u00a0V et al (2021) High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases. Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-021-07024-9","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"1188_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1634\/theoncologist.2019-0841","volume":"25","author":"GJ Hanna","year":"2020","unstructured":"Hanna\u00a0GJ et al (2020) The benefits of adjuvant trastuzumab for HER-2-positive salivary gland cancers. Oncologist 25(7):598\u2013608","journal-title":"Oncologist"},{"issue":"3","key":"1188_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.annonc.2019.11.018","volume":"31","author":"R Kurzrock","year":"2020","unstructured":"Kurzrock\u00a0R et\u00a0al (2020) Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a\u00a0phase IIa multiple basket study. Ann Oncol 31(3):412\u2013421","journal-title":"Ann Oncol"},{"issue":"2","key":"1188_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1200\/JCO.18.00545","volume":"37","author":"H Takahashi","year":"2019","unstructured":"Takahashi\u00a0H et al (2019) Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2\u2011positive salivary duct carcinoma. J\u00a0Clin Oncol 37(2):125\u2013134","journal-title":"J Clin Oncol"},{"issue":"9","key":"1188_CR28","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/lary.26516","volume":"127","author":"A Lee","year":"2017","unstructured":"Lee\u00a0A et\u00a0al (2017) Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma. Laryngoscope 127(9):2057\u20132062","journal-title":"Laryngoscope"},{"issue":"17","key":"1188_CR29","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1002\/cncr.29443","volume":"121","author":"AD Jensen","year":"2015","unstructured":"Jensen\u00a0AD et al (2015) Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival. Cancer 121(17):3001\u20133009","journal-title":"Cancer"},{"issue":"2","key":"1188_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.radonc.2015.01.002","volume":"114","author":"AD Jensen","year":"2015","unstructured":"Jensen\u00a0AD et al (2015) Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52\u00a0consecutive patients treated with raster-scanned carbon ion therapy. Radiother Oncol 114(2):182\u2013188","journal-title":"Radiother Oncol"},{"issue":"1","key":"1188_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijrobp.2018.12.049","volume":"104","author":"D Franceschini","year":"2019","unstructured":"Franceschini\u00a0D et\u00a0al (2019) Predictive factors for response and survival in a\u00a0cohort of oligometastatic patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 104(1):111\u2013121","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"1188_CR32","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1158\/1078-0432.CCR-21-1061","volume":"27","author":"EJ Kang","year":"2021","unstructured":"Kang\u00a0EJ et\u00a0al (2021) Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma. Clin Cancer Res 27(19):5272\u20135279","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1188_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijrobp.2019.09.036","volume":"106","author":"S Adeberg","year":"2020","unstructured":"Adeberg\u00a0S et\u00a0al (2020) The phase 1\/2 ACCEPT trial: concurrent cetuximab and intensity modulated radiation therapy with carbon Ion boost for adenoid cystic carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 106(1):167\u2013173","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1188_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0360-3016(93)90233-L","volume":"27","author":"GE Laramore","year":"1993","unstructured":"Laramore\u00a0GE et al (1993) Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 27(2):235\u2013240","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1188_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-8140(00)00273-5","volume":"59","author":"PE Huber","year":"2001","unstructured":"Huber\u00a0PE et\u00a0al (2001) Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 59(2):161\u2013167","journal-title":"Radiother Oncol"},{"issue":"Suppl","key":"1188_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0924-4212(96)84897-3","volume":"83","author":"A Kr\u00fcll","year":"1996","unstructured":"Kr\u00fcll\u00a0A et\u00a0al (1996) European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother 83(Suppl):125\u201319s","journal-title":"Bull Cancer Radiother"},{"issue":"1","key":"1188_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radonc.2011.12.013","volume":"103","author":"JE Mizoe","year":"2012","unstructured":"Mizoe\u00a0JE et\u00a0al (2012) Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 103(1):32\u201337","journal-title":"Radiother Oncol"},{"issue":"1","key":"1188_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1186\/s12885-021-08473-5","volume":"21","author":"K Lang","year":"2021","unstructured":"Lang\u00a0K et al (2021) Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a\u00a0prospective, open, randomized, two-armed, phase II study. BMC Cancer 21(1):812","journal-title":"BMC Cancer"},{"issue":"4","key":"1188_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ijrobp.2019.07.021","volume":"105","author":"T Held","year":"2019","unstructured":"Held\u00a0T et al (2019) Carbon Ion reirradiation for recurrent head and neck cancer: a single-institutional experience. Int J Radiat Oncol Biol Phys 105(4):803\u2013811","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1188_CR40","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ijrobp.2006.10.044","volume":"67","author":"AM Chen","year":"2007","unstructured":"Chen\u00a0AM et\u00a0al (2007) Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67(4):988\u2013994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"1188_CR41","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1088\/1361-6560\/aa6516","volume":"62","author":"T Tessonnier","year":"2017","unstructured":"Tessonnier\u00a0T et\u00a0al (2017) Experimental dosimetric comparison of (1)H, (4)He, (12)C and (16)O scanned ion beams. Phys Med Biol 62(10):3958\u20133982","journal-title":"Phys Med Biol"},{"key":"1188_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.radonc.2021.04.016","volume":"160","author":"M R\u00f6hrich","year":"2021","unstructured":"R\u00f6hrich\u00a0M et al (2021) (68)Ga-FAPI-PET\/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas\u2014Imaging analysis and histological validation. Radiother Oncol 160:192\u2013201","journal-title":"Radiother Oncol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-022-01188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-022-01188-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-022-01188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T11:08:59Z","timestamp":1680260939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-022-01188-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1007\/s00106-022-01188-4","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"type":"print","value":"0017-6192"},{"type":"electronic","value":"1433-0458"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"9 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Weusthof, J.\u00a0Debus und S.\u00a0Adeberg geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}